The Claim
In cognitively healthy adults aged 75 and older, current use of statins is associated with a 21% lower risk of all-cause dementia and a 43% lower risk of Alzheimer's dementia over a median follow-up of six years.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among adults aged 75 and older without cognitive impairment, those currently taking statins have a 21% lower rate of all-cause dementia and a 43% lower rate of Alzheimer's dementia over six years of follow-up.
See the scientific wording
In cognitively healthy adults aged 75 and older, current use of statins is associated with a 21% lower risk of all-cause dementia and a 43% lower risk of Alzheimer's dementia over a median follow-up of six years, suggesting that statin therapy initiated before cognitive decline may delay dementia onset.
Statins that can enter the brain lower cholesterol inside brain cells, which changes how a key protein is processed, leading to less buildup of toxic amyloid-beta clumps. These statins also calm inflammation in brain blood vessels and nerve tissue, which protects nerve cells from damage and slows the loss of memory and thinking skills.
What the research says
1 studyIn older adults without memory problems, those taking statins were less likely to develop dementia or Alzheimer’s over several years, according to this study. It doesn’t prove statins cause the reduction, but it shows a clear link.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.